Patents-Review.com
ClassID:

96985 ⎘

C07K14/57536 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Endothelin, vasoactive intestinal contractor [VIC]

Recent Application in this class:
#1
20260109760
2026-04-23

NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN

 #2
20220289836
2022-09-15

Anti-PACAP antibodies and uses thereof

 #3
20220195034
2022-06-23

NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN

 #4
20210380676
2021-12-09

METHODS OF DETERMINING WHETHER ANTI-PACAP ANTIBODIES INHIBIT PACAP-ASSOCIATED PHOTOPHOBIA OR LIGHT AVERSION

 #5
20210324068
2021-10-21

Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion

 #6
20210277106
2021-09-09

Methods of treatment with anti-PACAP antibodies

 #7
20210221884
2021-07-22

ANTI-PACAP ANTIBODIES

 #8
20210139845
2021-05-13

COMPOSITION FOR PROMOTING EFFICIENCY OF SOMATIC CELL REPLICATION

 #9
20200172612
2020-06-04

Anti-PACAP antibodies

 #10
20200079847
2020-03-12

Anti-PACAP antibodies

 #11
20190270807
2019-09-05

Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion

 #12
20190016773
2019-01-17

Endothelin-1 receptor based endothelin-1 sponge

 #13
20170298105
2017-10-19

Methods for treatment of stroke or cerebrovascular accidents using an ETreceptor agonist

 #14
20160361441
2016-12-15

Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia

 #15
20160304604
2016-10-20

Anti-PACAP antibodies

 #16
20140193393
2014-07-10

Methods for treatment of stroke or cerebrovascular accidents using an ETreceptor agonist

 #17
20140017808
2014-01-16

Prognosis and risk assessment in stroke patients by determining the level of marker peptides

 #18
20130309253
2013-11-21

Cancer treatment with endothelin receptor antagonists

 #19
20130296404
2013-11-07

Promoters exhibiting endothelial cell specificity and methods of using same

 #20
20130011367
2013-01-10

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

 #21
20120201790
2012-08-09

Promoters exhibiting endothelial cell specificity and methods of using same

 #22
20120148602
2012-06-14

Cancer treatment with endothelin receptor antagonists

 #23
20120093798
2012-04-19

Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist

 #24
20110263821
2011-10-27

PROGNOSIS AND RISK ASSESSMENT IN STROKE PATIENTS BY DETERMINING THE LEVEL OF MARKER PEPTIDES

 #25
20110207985
2011-08-25

PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS

 #26
20110201677
2011-08-18

PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME

 #27
20110129511
2011-06-02

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

 #28
20100081193
2010-04-01

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

 #29
20100003240
2010-01-07

Cancer treatment with endothelin receptor antagonists

 #30
20090326052
2009-12-31

Promoters exhibiting endothelial cell specificity and methods of using same

 #31
20090220587
2009-09-03

Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands

 #32
20070009945
2007-01-11

Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema

 #33
20060240091
2006-10-26

Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof

 #34
20050186179
2005-08-25

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

 #35
20050112110
2005-05-26

Promoters exhibiting endothelial cell specificity and methods of using same